Annual General Meeting approves all agenda items

The shareholders of the Company reaffirmed their trust in the Board of Management and the Supervisory Board and gave their approval to all items of the agenda by a large majority. The dividend distribution totals 0.15 euro per no-par value share with dividend entitlement.

In his report, Prof. Tobias Kaltenbach, chairman of the Board of Management of RHÖN-KLINIKUM AG, set out the development of the Company and the future challenges ahead. “For 2022 also, RHÖN-KLINIKUM AG can look back on a financially sound, albeit challenging financial year and has made a good start into 2023 – despite difficult conditions in the hospital sector and the economy as a whole. We have implemented many structural measures and further expanded our care offering, above all in the outpatient area.“

RHÖN-KLINIKUM AG’s strategic tasks continue to be the following areas of action: concentrating on its core activities, expanding outpatient care structures, optimising processes, expanding digital structures and offerings, as well as strengthening nursing and medical care.

The voting results and the report of the Board of Management on today’s Annual General Meeting are available at https://en.rhoen-klinikum-ag.com/agm.

You can find the 2022 Annual Report at: https://en.rhoen-klinikum-ag.com/…